iShares Nasdaq Biotechnology Index Fund News Headlines

IBB 
$337.1
*  
1.53
0.45%
Get IBB Alerts
*Delayed - data as of Sep. 4, 2015  -  Find a broker to begin trading IBB now
Exchange: NASDAQ

Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
ETF Details
Summary Quote ETF Detail Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
ETF NEWS
ETF Headlines Market Stream
FUNDAMENTALS
Short Interest Dividend History
 Save Stocks
Viewing
Filtered By
Ordered By

An Overview of Regeneron’s Business Model
9/4/2015 7:00:00 PM - Market Realist




Incyte Helps XBI to Outperform IBB’s Top 10
9/4/2015 4:35:00 PM - Market Realist


Benchmark Indexes Continue to Outperform IBB and XBI
9/4/2015 4:34:00 PM - Market Realist




Amgen Focuses Research on Cardiovascular Disease
9/4/2015 1:55:00 PM - Market Realist


Amgen’s Repatha Receives FDA Approval
9/4/2015 1:39:00 PM - Market Realist


An Overview of Amgen’s Business Model
9/4/2015 1:33:00 PM - Market Realist




Celgene’s High Valuation Compared to Peers
9/4/2015 11:07:00 AM - Market Realist


Celgene’s Unique Risks in Perspective
9/4/2015 9:06:00 AM - Market Realist






Celgene Announces Receptos Acquisition
9/3/2015 9:06:00 AM - Market Realist


The Biotech Compound Drug Insight
9/2/2015 3:15:00 PM - Seeking Alpha




Celgene’s EBITDA Margins Surpass Competitors
9/2/2015 11:06:00 AM - Market Realist




Celgene’s Expanding Oncology Pipeline
9/1/2015 11:06:00 AM - Market Realist


Celgene’s Aggressive Label Expansion Program
9/1/2015 9:06:00 AM - Market Realist






Biotech Weekly: Reviewing The <1x Book Biotech Screen
9/1/2015 8:00:00 AM - Seeking Alpha